Drug intelligence / Profile preview

clobetasone

Development stage
Phase 4
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical, Ophthalmic
01

Overview

Clobetasone is a synthetic corticosteroid used primarily as a topical medication to treat skin conditions such as eczema, dermatitis, and psoriasis. It is also sometimes used for certain ophthalmologic conditions like dry eyes. As a moderate-potency steroid (less potent than clobetasol), it works by binding to cytoplasmic glucocorticoid receptors in dermal and intradermal cells. This action induces inhibitory proteins that decrease the activity of inflammatory mediators such as prostaglandins, kinins, histamine, and liposomal enzymes. The result is reduced swelling (edema), redness (erythema), itching (pruritus), and irritation at the site of application[1][3][8]. Clobetasone may be combined with other agents such as antibiotics or antifungals in some formulations (e.g., Trimovate)[1].

Brand names
EumovateClobavateTrimovate
Other names
clobetasone butyrateClobetasona
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on clobetasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clobetasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call